- Home
- NRXP vs MYNA Comparison
NRXP vs MYNA Comparison
Compare NRXP & MYNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXP
- MYNA
- Stock Information
- Founded
- NRXP 2015
- MYNA 2009
- Country
- NRXP United States
- MYNA Germany
- Employees
- NRXP N/A
- MYNA N/A
- Industry
- NRXP Biotechnology: Pharmaceutical Preparations
- MYNA
- Sector
- NRXP Health Care
- MYNA
- Exchange
- NRXP Nasdaq
- MYNA Nasdaq
- Market Cap
- NRXP 48.5M
- MYNA 14.9M
- IPO Year
- NRXP N/A
- MYNA 2021
- Fundamental
- Price
- NRXP $4.01
- MYNA $0.44
- Analyst Decision
- NRXP Strong Buy
- MYNA
- Analyst Count
- NRXP 3
- MYNA 0
- Target Price
- NRXP $31.67
- MYNA N/A
- AVG Volume (30 Days)
- NRXP 2.8M
- MYNA 2.0M
- Earning Date
- NRXP 11-14-2024
- MYNA 01-28-2025
- Dividend Yield
- NRXP N/A
- MYNA N/A
- EPS Growth
- NRXP N/A
- MYNA N/A
- EPS
- NRXP N/A
- MYNA N/A
- Revenue
- NRXP N/A
- MYNA $5,957,776.00
- Revenue This Year
- NRXP N/A
- MYNA $203.73
- Revenue Next Year
- NRXP N/A
- MYNA $203.84
- P/E Ratio
- NRXP N/A
- MYNA N/A
- Revenue Growth
- NRXP N/A
- MYNA 21.89
- 52 Week Low
- NRXP $1.10
- MYNA $0.33
- 52 Week High
- NRXP $7.33
- MYNA $5.89
- Technical
- Relative Strength Index (RSI)
- NRXP 61.48
- MYNA 37.96
- Support Level
- NRXP $3.20
- MYNA $0.49
- Resistance Level
- NRXP $6.01
- MYNA $0.97
- Average True Range (ATR)
- NRXP 0.95
- MYNA 0.15
- MACD
- NRXP 0.11
- MYNA -0.01
- Stochastic Oscillator
- NRXP 56.52
- MYNA 4.32
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About MYNA Mynaric AG American Depository Shares
Mynaric AG operates in the communication equipment business sector. The company is engaged in the manufacture and sale of products and projects and the provision of services in the field of laser technology, in particular in the aerospace, telematics, and satellite services sectors. It operates in two segments: Air and Space. The space segment comprises CONDOR terminals, and the Air segment comprises HAWK terminals. The company's product portfolio consists of Optical ground stations, Air-to-ground terminals, Air-to-air terminals, Space terminals, and Custom products and subcomponents. Its applications consist of high-altitude networks, remote eyes, satellite constellations, earth observation satellites, and others. Geographically, its key revenue is derived from the United States.